GSK Investigational Site

Sydney, Nova Scotia B1S 2E8

0 studies enrolling now · 2 studies all time

What they study most

Depressive Disorder, Schizophrenia

Studies at this site

• A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder — Stopped early
• Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia — Completed